Exploring the Effect and Mechanism of Liraglutide in Treating Depression Based on Network Pharmacology and Experimental Analysis
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Jiangjin Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Clinical Medical College of Jilin University (The Second hospital of Ji…. Hauptthemen laut MEDLINE: Liraglutide, Depression, Network Pharmacology, Antidepressive Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Development Plan Project of Jilin Province, China.
Themen: Depression
Abstract (Originalsprache)
Depression is a disorder caused by various reasons, with low mood as the main symptom, and it has a serious impact on mental health. Liraglutide (Lir) has been confirmed to alleviate neuroinflammation and depression‐like behaviours induced by chronic stress, but its underlying mechanisms remain unclear. This study investigated the regulation of Lir for microglia‐associated inflammation in depression through network pharmacology. In vivo experiments demonstrate that Lir reduces depressive‐like behaviours by activating Nrf2 and subsequently downregulating HMGB1 expression, while also reducing the generation of pro‐inflammatory mediators and oxidative stress damage. In vitro studies confirmed that the downregulation of HMGB1 depends on Nrf2 activation, and Lir activates Nrf2 via the PI3K/AKT pathway. Additionally, indirect co‐culture of BV2 and HT22 cells demonstrated Lir's neuroprotective effects against neuronal apoptosis, consistent with findings from in vivo experiments. The study results first demonstrate that Lir exerts antidepressant effects through the PI3K/Nrf2/HMGB1 pathway, which reveals a novel mechanism of action for the antidepressant effects of Lir.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Clinical Medical College of Jilin University (The Second hospital of Jilin University), Changchun, China.
- Department of Neurology, The Second Clinical Medical College of Jilin University (The Second hospital of Jilin University), Changchun, China.
- Department of Endocrinology, The Second Clinical Medical College of Jilin University (The Second Hospital of Jilin University), Changchun, China.
Förderung
- National Natural Science Foundation of China
- Science and Technology Development Plan Project of Jilin Province, China
Zitieren
APA
Sun, J., Fu, X., Liu, Y., Wang, T., Zhao, X., Cui, R., & Yang, W. (2025). Exploring the Effect and Mechanism of Liraglutide in Treating Depression Based on Network Pharmacology and Experimental Analysis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70630
Vancouver
Sun J, Fu X, Liu Y, Wang T, Zhao X, Cui R, et al. Exploring the Effect and Mechanism of Liraglutide in Treating Depression Based on Network Pharmacology and Experimental Analysis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70630
BibTeX
@article{Sun2025,
author = {Sun, Jiangjin and Fu, Xiying and Liu, Yaqi and Wang, Tian and Zhao, Xing and Cui, Ranji and Yang, Wei},
title = {Exploring the Effect and Mechanism of Liraglutide in Treating Depression Based on Network Pharmacology and Experimental Analysis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70630}
}
EUVIMED